SCOPE 2024 - Mural Health keen to focus on patient centricity and diversity

By Liza Laws

- Last updated on GMT

© Mural Health
© Mural Health

Related tags SCOPE 2024 Mural Health Patient centricity Data management patient engagement patient diversity

Sam Whitaker is co-CEO and co-founder at Mural Health.

Mural Health represents a natural evolution to Sam’s past work; the Mural Link product leverages a next-generation participant payment technology to drive deeper benefits to the participants and more meaningful value to both sites and sponsors executing the study.

Prior to co-founding Mural Health, Sam founded Greenphire in 2008, where he was responsible for inventing the first payment technologies that were vertically integrated into the clinical trials industry.

Sam is from suburban Philadelphia (Delco!) and is a graduate of the University of Pennsylvania.

Why do you think it is important to attend SCOPE?

Attending SCOPE is valuable for staying informed about industry trends, particularly the emphasis on 'patient-centricity' and 'diversity'. It provides a platform for networking and gaining insights into how companies navigate these important issues.

What do you hope to achieve this year while you are there?

My goal this year is to deepen my understanding of how different companies approach ‘patient-centricity’ and ‘diversity’ initiatives. I aim to establish meaningful connections and gather insights that can be applied in my professional endeavors.

Do you have an inkling what the buzz theme will be this year?

We are anticipating a focus on ‘patient-centricity’ and ‘diversity’ as prevalent themes, fostering an environment where companies share their strategies and best practices. The conference is expected to maintain a positive tone, with discussions centered around industry advancements.

For those who have never attended SCOPE before, what would you say to entice them?

For newcomers, SCOPE offers a unique opportunity to engage with industry leaders and gain a comprehensive understanding of how companies address "patient-centricity" and "diversity" concerns. It's a platform for learning and collaboration.

What part of it are you looking forward to the most?

I am eager to attend various talks and presentations that delve into the practical applications of ‘patient-centricity’ and ‘diversity’. Additionally, reconnecting with colleagues and peers to share insights and experiences is a highlight of the conference for me. 

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers